Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Rheumatology, Allergy and Immunology
Mass General Program One of the Few in the World to Focus on Vasculitis Patients
Sebastian Unizony, MD, and Zachary S. Wallace, MD, MSc, co-directors of the Vasculitis Program at Massachusetts General Hospital, discuss the program's multidisciplinary approach to care and pioneering research efforts.
Featured In Cardiovascular
New Program Helps High School Students Explore Careers in Cardiology
A Massachusetts General Hospital cardiology fellow launched You Belong in Cardiology to build a pipeline for women and underrepresented minorities in cardiology.
Featured In Digestive Health
AGA Guideline Makes the Case for Biomarkers in Managing Crohn's Disease
Ashwin Ananthakrishnan, MD, discusses the AGA guideline's key recommendations for managing Crohn's disease and the evolving role of biomarkers in these treatments.
Featured In Orthopaedics
Inferior Screw Placement Drastically Improves Revision THA Outcomes
Massachusetts General Hospital researchers have determined that inferior screw fixation drastically reduces failure after revision total hip arthroplasty.
Featured In Oncology
Revolutionizing Cancer Immunotherapy for Melanoma and Beyond
Researchers at Massachusetts General Hospital won a Breakthrough Award to enhance personalized approaches to immunotherapy for metastatic melanoma.
The Latest Neuroscience Advances
Essential Tremor Treatment Advancements Using MRI-guided Focused Ultrasound: Q&A With Jeffrey S. Schweitzer, MD, PhD
Jeffrey S. Schweitzer, MD, PhD, a neurosurgeon at Massachusetts Hospital, specializing in treating epilepsy, essential tremor, and tremor-dominant Parkinson's diseases. In this Q&A, Dr. Schweitzer discusses the physiological processes underlying essential tremor and the advancements.
Imaging Technology Advances Multiple Sclerosis Research
Massachusetts General Hospital is developing and testing new imaging techniques to better understand multiple sclerosis (MS) pathology, physical symptoms and cognitive impairment associated with MS.
Contributing Physicians
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Sydney S. Cash, MD, PhD
Co-Director, Center for Neurotechnology and Neurorecovery, Associate, Department of Neurology, Massachusetts General Hospital, Professor of Neurology, Harvard Medical School
Advances Specialties
Endocrinology
In Utero Exposure to SARS-CoV-2 May Increase the Risk of Cardiometabolic Disease
Massachusetts General Hospital researchers found that infants who have in utero exposure to maternal SARS-CoV-2 exhibit lower birth weight followed by accelerated weight gain in the first year of life, a pattern thought to increase the risk of obesity and cardiometabolic disease in childhood and adulthood.
Ophthalmology
The Neuropeptide Alpha-Melanocyte–stimulating Hormone Prevents Persistent Corneal Edema After Injury
Reza Dana, MD, MSc, MPH; Jia Yin, MD, PhD, MPH; Ula V. Jurkunas, MD; and colleagues have discovered a critical role for neuropeptides in maintenance of corneal endothelial cells and potential therapeutic applications for α-melanocyte–stimulating hormone after corneal injury or intraocular surgery.
Orthopaedics
Pathways Case Record: Profound Weight Loss in a Patient With Polymyositis and Small Bowel Inflammation
A patient presented with severe malnutrition and an unintentional estimated weight loss of 160 pounds over three years. The Pathways Consult Service at Massachusetts General Hospital investigated the patient's concomitant skeletal and smooth muscle inflammation and gut dysmotility.
May 10, 2024
Conference: Midlife Women's Health 2024: A Multidisciplinary Approach to Care
The Midlife Women's Health 2024 course is led by a multidisciplinary group of experts from Massachusetts General Hospital who will present on the evaluation and management of gynecologic cancers, cardiovascular health, menopausal hormone therapy, ADHD, sexuality after cancer, and more to assist clinicians in caring for their midlife patients. The entire program will be available to registrants for 30 days after the event, with CME credit provided only to those who log in on the day of the conference.
April 13-18, 2024
Conference: AAN 2024: The American Academy of Neurology Annual Meeting
Neurology leaders from Massachusetts General Hospital will present their latest research at the American Academy of Neurology (AAN) 2024 Annual Meeting. This hybrid event takes place both in-person in Denver, CO, and virtually on April 13–18, 2024.
